Thrombosis in horses refers to the formation of blood clots within blood vessels, which can impede normal blood flow and lead to various health issues. This condition can occur in both veins and arteries, affecting different parts of the equine circulatory system. Thrombosis can result from a variety of factors, including endothelial damage, changes in blood flow, and alterations in blood composition. In horses, common sites for thrombosis include the jugular vein and digital veins. Clinical signs may vary depending on the location and severity of the clot. This page compiles peer-reviewed research studies and scholarly articles that explore the pathophysiology, diagnosis, and management of thrombosis in horses, providing insights into its impact on equine health and potential treatment strategies.
is one of the most pathogenic nematodes affecting equids. Larval migration through the cranial mesenteric artery (CMA) with attendant arteritis and thromboembolism can result in fatal non-strangulating intestinal infarction. Once considered a historical disease, recent studies have described the reemergence of this pathogen in several European countries; however, little is known of the current prevalence of in the Canadian horse population. Unassigned: To determine the prevalence of active cranial mesenteric arteritis in horses submitted for postmortem examination to the Diagnostic Services...
Herschl MA, Trim CM, Mahaffey EA.Twelve horses of various breeds and either sex were anesthetized with xylazine and ketamine injected into a median or lateral thoracic vein. During anesthesia, with the horse in sternal recumbency, a 14-gauge, 8.9 cm catheter was inserted into each jugular vein by using aseptic technique. Guaifenesin in water (100 mg/kg or a maximum dose of 50 grams) was infused into one jugular vein and an equal volume of 0.9% saline solution was infused into the other jugular vein. Seven horses received 10% guaifenesin, and five horses received 5% guaifenesin. The catheters were removed before the horses rec...
Wallace GE, McKaba VF, Reinhart JM, Li Z, Austin S, Fries RC.Large vessel and microvascular thrombi are common complications in systemically ill horses contributing to patient morbidity and mortality. Apixaban, an oral factor Xa inhibitor, shows excellent efficacy against stroke and deep vein thrombosis in humans. The purpose of this study was to determine serum apixaban concentrations and anti-factor Xa activity in horses after orally administered apixaban. Five horses received a single dose of intravenous (0.09 mg/kg) and oral (1 mg/kg) apixaban in a cross-over design. Serum apixaban concentrations and anti-Xa activity were measured serially via liq...